Since a large body of data has suggested a significant role for alpha-fetoprotein (AFP) in the regulation of the immune response at a number of levels, we examined the possibility of a specific receptor for AFP on the immune recognition cell, the monocyte/macrophage. Microscopic autoradiography exhibited an obvious binding of AFP almost exclusively on human peripheral monocytes but not on lymphocytes. In a human monocyte cell line (U937) Scatchard plot analysis indicated the presence of two distinct AFP-specific binding sites with a Kd of 5 X 10-11 M, 49 binding sites per cell, and 2.5 X 10-7 M, 7,800 binding sites per cell. 125I-ASD-AFP, AFP-radiolabeled bifunctional photoactivatable thio-cleavable cross-linker, was used to isolate the AFP binding protein from U937 cells. After ultraviolet photoactivation, 125I-sulfosuccinimidyl 2-(p-azidosalicylamido)ethyl-1,3'-dithiopropionate was covalently linked to the putative receptor. Autoradiography of SDS gradient PAGE under reducing conditions showed a major radiolabeled band at between 62 and 65 kD. To confirm the specificity of the finding, recombination of AFP with the isolated receptor was examined in artificially reconstituted membrane vesicles, which also resulted in a single band at 62-65 kD by SDS-PAGE autoradiography. From the data above, we concluded that human monocytes possess a specific AFP binding protein on the membrane, a putative receptor, which may be involved with the physiological regulation of the immune response. (J.
Introduction
Alpha-fetoprotein (AFP)' is the predominant serum globulin in early fetal life and is synthesized mainly by the yolk sac and fetal liver. However, AFP can be detected in a variety of cells and tissues other than the yolk sac and liver during ontogenesis ( 1, 2) , presumably because AFP is internalized into these cells or tissues but not synthesized there. Uriel been demonstrated the specific uptake ofAFP by certain malignant cells (3) (4) (5) . They have shown kinetic analysis for putative receptors on blast transformed lymphocytes as well as on a murine T lymphoma cell line, but not on normal resting lymphocytes (6, 7) . In these reports, the authors suggested that AFP and AFP receptors may regulate the transfer of polyunsaturated fatty acids into cells undergoing growth and proliferation.
In addition, numerous studies have documented the effects of AFP on various aspects of the immune function and have suggested that it plays an important immunoregulatory role.
Previous studies have demonstrated inhibition ofnatural killer cell activity (8) , the induction of T suppressor cells (9-1 1 ) the inhibition of mitogenic responses to PHA and Con A (12) (13) (14) (15) , the inhibition of T cell proliferation to Ia determinants ( 16) , decreased macrophage phagocytosis ( 17, 18) , and decreased macrophage Ia expression ( 19, 20) . Thus, the present study was undertaken to determine if the effects of AFP on immune function was mediated by a cell surface receptor on the immune recognition cell, the monocyte/macrophage. It has been reported that human monocytes/macrophages express receptor activities to a number of essential substances, including IgG-Fc (21, 22) , interleukin 1 (23) , interleukin 3 (24) , C-reactive protein (25) , tumor necrosis factor (26) , IgE-Fc (27, 28) , maleyl-albumin (29, 30) , transferrin (31) , ceruloplasmin (32) , and urokinase (33) . It is notable that the identity of an identical Fc receptor on both peripheral monocytes and monocyte cell line (U937) was documented (34) , enabling further study due to the great convenience, as well as the defined characteristics of this established monocytic cell line. Also, AFP was demonstrated in macrophages in amniotic fluids with neural tube defects (35) and in granulomatous inflammation of the mouse (36) . 8 ,000 rpm for 14 s. Immediately after the separation, the supernatant was carefully removed and the tip, which contained the cell pellet, was cut and the radioactivity counted by gamma counter. Internalization of '25I-AFP was determined by eluting the cell-bound '25I-AFP with 5 mM acetic acid containing 135 mM NaCl and 2.5 mM KCl, pH 3.6, sedimenting the washed cell pellet on 10% sucrose, and solubilizing the cell pellet with 1 N NaOH. The residual radioactivity solubilized by NaOH represented the internalized '251-AFP (39 Cross-linking of'25I-SASD-AFP on U937. A vol of 2 X 108 U937 cells was washed with Hanks' solution three times, and preincubated with 2% polyvinylpyrolidone, mol wt 40,000, in RPMI for 30 s to reduce nonspecific binding (40) . The cells were subsequently incubated with 50 Mg of '251-ASD-AFP in a final vol of 2 ml for 30 min at room temperature. The cells were washed three times with cold PBS to remove free ligand and resuspended in 2 ml ofcold PBS. 1 ml ofthe cell suspension was transferred to a borosilicate glass tube and photoactivated for 2 min on ice with a high intensity long wave ultraviolet (UV) light (Blak-Ray, San Gabriel, CA) at 100 W, 10 cm from the light source.
Identification ofAFP receptor. After ultraviolet irradiation, one aliquot of the cells was washed two times with cold PBS and solubilized with 0.5% (vol/vol) Triton X-100 in PBS, pH 7.0, containing 0.2 mM PMSF, 0.1 mM EDTA, and 1 trypsin inhibitor unit/ml of aprotinin (Sigma Chemical Co.) for 30 min at 4VC with continuous shaking. Another aliquot ofnonirradiated cells was submitted directly to solubilization as a control. The cell lysates were centrifuged at 34,000 g for 30 min to remove nonsolubilized protein, and the supernatants were applied to a hydrophobic absorbent column (Bio-Beads SM-2; Bio-Rad Laboratories) to remove the detergent. The first peak of radioactivity from the eluate was collected and concentrated by a microconcentrator (Centricon 10; Amicon, Beverly, MA). The samples were dissolved in Laemmli buffer (41), separated on a 5-20% linear gradient SDS-PAGE under reducing or nonreducing conditions. After electrophoresis, the gel was fixed with 13.5% (wt/vol) trichloroacetic acid, 3.5% (wt/vol) sulfosalicylic acid, and H20. The protein bands were visualized by conventional Coomassie brilliant blue staining method. Subsequently, the gel was miniaturized by immersing into 30% polyethylene glycol (average mol wt 2,000) in Tris-glycine buffer for 2 h (42), and dried carefully by gel dryer. Finally, the radiolabeled protein bands were detected by autoradiography.
All the above procedures before the photoactivation were performed in a photographical dark room under a safe light and the samples were covered by aluminum foil.
Reconstitution of membrane receptor. Recombination of ligand with the isolated receptor was examined in artificially reconstituted membrane vesicles. An aliquot of 2 X 108 U937 cells was prewashed with PBS and sonicated under hypotonic condition (10 mM Hepes buffer, pH 7.0, in the presence of0.5 mM PMSF, 0.1 mM EDTA, and 1 trypsin inhibitor unit/ml of aprotinin. Crude membrane fractions were obtained by centrifugation of the crushed cells in 60% sucrose at 400 g for 30 min, followed by 2,000 g for 60 min (43) . The method of Kagawa et al. (44) was adopted for the proteoliposome reconstitution system with some modification. Briefly, the membrane fraction was solubilized with 2% sodium cholate (Sigma Chemical Co.), 2% soybean lecithin (Calbiochem Corp., La Jolla, CA) in 1 ml ofPBS containing a cocktail ofproteolytic inhibitors, as described above, for 30 min at 4°C. Unsolubilized membrane residue was removed by centrifugation at 34,000 g for 30 min and the supernatant was prepared for further reconstitution studies. Preliminary experiments showed that the supernatant from the membrane fraction of I x 108 U937 cells contained -500Mgg ofprotein measured by BCA protein assay kit (Pierce Chemical Co., Rockford, IL). The incorporation of solubilized membrane proteins into liposomes was carried out by applying this supernatant to Bio-Beads SM-2 column (Bio-Rad Laboratories) (for removal ofdetergent) instead of extended dialysis. The opaque effluent in the void volume, consisting of reconstituted membrane vesicles, was collected and immediately incubated with 50Mgg of '25I-SASD-AFP for 60 min at 4°C in the dark room. After incubation, bound and free ligands were separated by Sephadex G-200 column (0.7 X 50 cm) chromatography under safe light and each fraction was exposed to UV light. After counting the radioactivity, some ofthe fractions were selected, concentrated, and finally analyzed by SDS-PAGE autoradiography in the same manner as described above. To minimize proteolytic degradation of the receptor protein, both Bio-Beads SM-2 (Bio-Rad Laboratories) and Sephadex G-200 columns were previously equilibrated with PBS containing a cocktail of proteolytic inhibitors.
Results
Specific binding ofAFP to human peripheral monocytes. 125[ AFP was incubated with human peripheral monocytes. A typical and representative autoradiogram is shown in Fig. 1 . After 1 h of culture in the absence of serum, the majority of mononuclear cells nonselectively attached to the chamber slides. Nonspecific esterase staining showed that -15% were monocytes in all experiments, with the majority of lymphocytes loosely adhering. Silver grains were observed almost exclusively on U Figure 1 . Autoradiogram of human peripheral monocytes incubated with '25I-AFP. Human peripheral mononuclear cells were isolated by Ficoll density centrifugation and incubated with 500 ng/ml of '25I-AFP followed by microscopic autoradiography. Nonspecific esterase staining showed -15% were monocytes. Silver grains were observed on monocytes (indicated by the arrows) but were virtually undetected on lymphocytes. monocytes (indicated by the arrows) but were virtually undetected on resting lymphocytes. These data suggested a specificity of AFP binding to monocytes.
Specific binding ofAFP to U937 and THP-J . The binding capacity of labeled AFP to both cell lines was further investigated at multiple time points within 60 min and at AFP concentration ranging from 0.36 to 3,000 ng/ml. AFP binding was completely blocked by the previous addition of unlabeled AFP but not by HSA or human IgG, confirming the specificity of the binding. Preliminary experiments indicated that all AFP binding sites were saturated within 30 min after incubation at room temperature. The binding curve with U937 showed two saturation plateaus: plateau I ranged from -0.4 to 6 ng/ml and plateau II ranged from about 150 to 3,000 ng/ml of AFP concentration (Fig. 2, A and C) . Nonspecific binding was < 15% at any AFP concentration examined.
Dissociation experiments indicated that -50% ofthe total binding was internalized within 60 min at room temperature (data not shown).
Scatchard plot analysis revealed that plateau I had a Kd of 5 x 10"-M and 49 binding sites per cell (Fig. 2 B) , and plateau II had a Kd of 2.5 x 10 -7 and 7,800 binding sites per cell (Fig. 2  D) . A similar curve was noted in the second monocyte cell line, THP-1, with two plateaus with Kd of 2 X 10" M, and 1.2 x 10-9 M, in the range of 0.4-5 ng/ml, and 20-100 ng/ml of AFP concentration, respectively (data not shown).
Identification and reconstitution ofAFP receptor. The putative AFP receptor protein was isolated as a major sharp radiolabeled band at -65 kD by SDS-PAGE under reducing conditions followed by autoradiography (Fig. 3, lane C) . Under nonreducing conditions, a single band was observed at -50 kD (Fig. 3, lane D) . The bands were distinctly different from directly labeled AFP (Fig. 3, lane A) , and were reproducible. The same receptor, with identical molecular mass on SDS-PAGE, was identified when the labeled AFP used as ligand was obtained from different sources, as well as when the cell membranes were extracted with different detergents, SDS or Triton X-100. No obvious bands were detected from the samples that had been incubated with 1251I-SASD-AFP, but that had not been photoactivated (Fig. 3, lane E) . As an additional control, 1251I ASD-AFP alone was photoactivated in advance and run in the gel, which showed exactly the same mobility as that of unconjugated native 1251I-AFP (Fig. 3, lane B) , indicating that neither conjugation to the cross-linker nor the act of photoactivation altered AFP mobility. In addition, '25I-SASD-AFP when photoactivated ran identically under both reducing and nonreducing conditions.
In the proteoliposome reconstitution experiments, the most successful incorporation of the membrane proteins into liposomes was made when the lipid-to-protein ratio was 20:1 (wt:wt). color in the void volume. The recombinant vesicles bound to the ligand were successfully separated from free ligand by gel filtration and eluted as the peak I of radioactivity in the void volume (Fig. 4 A, open circle) . After analysis by SDS-PAGE autoradiography, one aliquot from the peak I showed a major band at 62-65 kD (Fig. 4 B, lane A) , while an aliquot from the peak II resulted in major band at 72 kD (Fig. 4 B, lane B) , identical with that of control '25I-AFP (Fig. 4 B, lane C) .
Discussion
In this study, we demonstrated an obvious specific binding of purified AFP to human peripheral monocytes but not to resting lymphocytes. This result led us to pursue the characterization of this putative AFP receptor on U937 and THP-1 cell lines which retain many monocyte characteristics. The binding of AFP to the immunorecognition cell was first recognized on the rat peritoneal macrophage ( 18). Uriel and colleagues later demonstrated that normal lymphocytes do not bind AFP. However, blast-transformed or malignant lymphocytes specifically bound AFP and the binding kinetics were studied (6, 7). Therefore, AFP may bind to specific receptors on monocytes/macrophages as well as on activated T lymphocytes with malignant or blastic transformation, but not resting T lymphocytes. Our study ofthe binding kinetics to U937 in the present report indicates the presence of two distinct putative receptors activities: one with high affinity and low capacity (Kd of 5 x 10-11 M, 49 binding sites per cell) and the other with low affinity and high capacity (Kd of2.5 x l0-7 M, 7,800 binding sites per cell). Similar data were obtained in a second monocyte-derived cell line, THP-1. A similar group of AFP binding sites with high affinity and low capacity, was also reported previously on rat peritoneal macrophages (Kd of 2.5 x 101-2 M and 10 binding sites per cell) (18). Naval et al. evaluated three AFP binding sites in a murine T lymphoma cell line (Kd of2.2 X l0-9 M, 8 .6 x 10-7 M, and 5.7 x 10-6 M, and 700, 210,000, and 910,000 binding sites per cell, respectively) (6) and similar relatively low affinity and high capacity sites were characterized in human T lymphocytes with PHA blast formation (Kd of 3.03 X 10-7 M, 88,500 binding sites per cell) (7). These kinetic data not only suggest a cell specificity but also suggest the presence of similar receptor groups in the two cell types that may be involved in different biological functions. In fact, Haberland (Fig. 3,   lane D) . This slightly fast moving band appeared to be smaller than the receptor isolated under reducing conditions. This phenomenon can be partially explained ifthe receptor contained a globular structure maintained by disulfide bonds, such that it runs faster in nonreducing gels than that under reducing conditions as previously demonstrated (24, 49 In general, the yields ofreceptor purification should mainly be due to the number of the cells used and the density of specific binding sites on each cell. For example, Ghinea et al. reported the identification of a putative albumin receptor using SASD from the rat microvascular endothelial cells and achieved a radioactive band on ligand blotting on a nitrocellulose membrane, in spite of strongly denaturing conditions (40) . This was probably due to an extremely high density of albumin binding sites on those cells which had been estimated to be 3 X 106 sites per cell by Schnitzer et al. (51) . In the present study, we had to minimize the proteolytic degradation (52), use nondenaturing conditions as well as high resolution SDS-PAGE (42) , because the estimated number of receptors in U937 was lower.
In these studies, we also found that the receptor-ligand complex could not be precipitated by adding an appropriate amount of anti-AFP antibody, nor removed by anti-AFP affinity column chromatography (data not shown). This suggests that the antigenic epitope of AFP may localize closely to its receptor binding sites or they have a partially common structure. This phenomenon has been previously reported with the antibody against IgG Fc receptor on human monocytes shown to inhibit the ligand-receptor binding (53) .
To confirm the specificity of the putative receptor identified by SDS-PAGE, recombination of the receptor-ligand was examined in a semiartificial and more defined membrane environment, the proteoliposome reconstitution system. As described above, it is also advantageous for the receptor protein to minimize the time to be exposed to any detergent in the reconstitution step as well as in the following recombination step with the ligand. Therefore, detergent removal was performed by using SM-2 column instead of a prolonged dialysis. We found specific binding of AFP with the liposomes consisting of soybean lecithin, with membrane receptor.
A sharp, single band with high density was obtained at 65 kD which reconfirmed the specificity of the band obtained in the previous analytic study. Under these conditions, the ligand would not be subjected to degradation or recycling as compared with incubation with living cells. Recent unpublished data, using electron microscopic techniques in our laboratory, revealed that AFP is internalized into monocytes via typical receptor mediated endocytosis. Finally, we conclude that human monocytes possess specific AFP binding proteins on the membrane, a putative receptor, which may be involved with the physiological regulation of the immune response. This putative AFP receptor was biochemically characterized as having a molecular mass of 65 kD and was confirmed in a reconstituted receptor proteoliposome system. Studies are in progress to determine the precise mechanism ofhow the receptor-ligand interaction mediates the reported changes in monocyte function.
